LIVANOVA PLC DELAYED NOTIFICATION OF MAJOR INTEREST IN SHARES

25 april 2016

Set out below are the TR-1 notifications of a major interest in shares that were received by LivaNova PLC (the "Company") from each of BlackRock Inc, on 22 October 2015, and Paulson & Co. Inc, on 5 January 2016. Due an administrative oversight, the Company did not release these announcements at the appropriate time. The Company regrets this late notice to the market and would like to apologise for the delay. The Company confirms that it has corrected the gap in its systems to ensure that future TR-1 notifications are identified quickly and notified to the market in compliance with DTR 5.8.12.

About LivaNova

LivaNova PLC, headquartered in London, UK, is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems. The company employs approximately 4,500 employees worldwide. With a presence in more than 100 countries, LivaNova operates as three business units: Cardiac Rhythm Management, Cardiac Surgery, and Neuromodulation, with operating headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S.), respectively.

LivaNova is listed on NASDAQ and listed on the Official List of the UK's Financial Conduct Authority and traded on London Stock Exchange (LSE) under the ticker symbol "LIVN." For more information, please visit www.livanova.com , or contact:

Investor Relations and Media

Karen King
Vice President, Investor Relations & Corporate Communications
Phone: +1 (281) 228-7262
Fax: +1 (281) 218-9332
e-mail: corporate.communications@livanova.com  

- End -

For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			Livanova PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other: Position acquired following the merger of Sorin Spa and Cybertronics
3. Full name of person(s) subject to the notification obligation: iii	BlackRock, Inc.
4. Full name of shareholder(s)  (if different from 3.): iv
5. Date of the transaction and date on which the threshold is crossed or reached: v	19 October 2015
6. Date on which issuer notified:	22 October 2015
7. Threshold(s) that is/are crossed or reached: vi, vii	Total holding has gone above 5% Voting rights attached to shares holding has gone above 5%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00BYMT0J19

Below 5%

Below 5%

N/A

N/A

3,721,152

N/A

7.62%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

CFD

3,906

Nominal

Delta

0.01%

0.01%

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,725,058

7.63%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	BlackRock Regulatory Threshold Reporting Team
14. Contact name:	Gareth Slade
15. Contact telephone number:	020 7743 2536

For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			Livanova PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other: Disclosure by the issuer of the total number of votint rights following a Corporate Action, being the cross-border merger of Sorin S.p.A. and Cyberonics, Inc. to create LivaNova PLC.					Yes
3. Full name of person(s) subject to the notification obligation: iii	Paulson & Co. Inc.
4. Full name of shareholder(s)  (if different from 3.): iv
5. Date of the transaction and date on which the threshold is crossed or reached: v	19 October 2015 (See Section 13 (Additional Information))
6. Date on which issuer notified:	05 January 2016 (See Section 13 (Additional Information))
7. Threshold(s) that is/are crossed or reached: vi, vii	Increase above 5%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00BYMT0J19

N/A

N/A

N/A

N/A

3,378,285

N/A

6.91%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

CFD

117,600

Nominal

Delta

0.24%

0.24%

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,495,885

7.15%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	Position reflects effect of Corporate Action, the total number of voting rights in respect of which was only disclosed by the issuer on 31 December 2015.
14. Contact name:	Greg Bowne Senior Vice President, Finance
15. Contact telephone number:	+1 281 228 7262

---